admin1

OPTIMISTmain
OPTIMISTmain

Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Lead PI: Professor Craig Anderson Status: Recruiting, Site selection No. of Patients Currently Recruited: 18 …

Pacific-Stroke
Pacific-Stroke

Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study (PACIFIC-STROKE)…

PESTO

 A Prospective multicentre, phase 2b randomised controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality…

RECAPS
ReCAPS

Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke ReCAPS: Recovery-focused Community support to Avoid readmissions and improve Participation…

ReMEDY

A Randomised, Double Blind, Placebo-controlled Phase II Multicentre Evaluation to Assess the Safety and Tolerability of DM199 Administered Intravenously and…

RESTORE

Randomised Efficacy and Safety Trial with Oral S 44819 after Recent ischaemic cerebral Event Lead PI: Prof Geoff Donnan Status: Closed to…

siciario logo on poster
SICARIO

Expanding stroke therapy access: Stroke in patients with large ischemic core Co-Principal Investigator: Prof Chris Levi Co-Principal Investigator: Dr Carlos…

STOP-AUST

The Spot sign and Tranexamic acid on Preventing ICH growth- AUStralasia Trial Lead PI: Prof Geoff Donnan & Prof Steve Davis…

STOP-MSU

Stopping haemorrhage with Tranexamic acid for hyperacute Onset Presentation including Mobile Stroke Units Lead PI: Prof Stephen Davis, Prof Geoff Donnan,…

1 2 3 4